MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
International Journal of Radiation Oncology*Biology*Physics
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,661 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,661 works in the cohort · of 4,299,418page 30 of 74

Labels cover 5 of 3,661 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,661 of 3,661 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)
Rachel Glicksman, Andrew Loblaw, Gerard Morton, Danny Vesprini, Ewa Szumacher, Hans T. Chung +8 more
2023· article· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
6
citations
affno abstractunlabeled
[no title]
Edward Kai‐Hua Chow, Cyril Danjoux, Ruth Connolly, L. Andersson, Joel Finkelstein, Ewa Szumacher +1 more
2000· letter· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · insufficient_payloadconsensus · none
6
citations
affno abstractunlabeled
Treatment planning aids in prostate cancer: friend or foe?
Shawn Malone, R. Donker, Simone Dahrouge, Libni Eapen, I. Aref, Gad Perry +1 more
2001· article· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
6
citations
affno abstractunlabeled
In Reply to Smith and Eifel
Kathy Han, Michael Milosevic, Anthony Fyles, Akila N. Viswanathan
2014· letter· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
6
citations
affno abstractunlabeled
Long-Term Update of NRG Oncology RTOG 94-08
Christopher U. Jones, S. Pugh, Howard M. Sandler, Michael Chetner, Mahul B. Amin, Jason A. Efstathiou +13 more
2018· article· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affno abstractunlabeled
SBRT for Central Tumors in Early Stage NSCLC Patients
Barbara Stam, I.S. Grills, Margriet Kwint, Matthias Gückenberger, Frederick Mantel, Andrew Hope +4 more
2017· article· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affno abstractunlabeled
Adapt or Perish: Adaptive RT for NSCLC
Pamela Samson, Dawn Owen, Shankar Siva, Megan E. Daly, Meredith Giuliani
2024· article· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affno abstractunlabeled
A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) With Concurrent Cisplatin and Bevacizumab (Bev) Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer: One-Year Results from RTOG 0921
Anand Viswanathan, Jennifer Moughan, Brigitte Miller, Ying Xiao, Ursula A. Matulonis, Neil S. Horowitz +4 more
2013· article· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
5
citations

How this was built: Screen · Findings · About